Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

71 results about "Heavy chain gene" patented technology

Bombyx mori silk fibroin heavy chain gene mutant obtained by utilizing CRISPR/Cas technology and mutation method and application

The invention discloses a bombyx mori silk fibroin heavy chain gene mutant obtained by utilizing CRISPR / Cas technology and a mutation method and application. The mutation method includes: mixing cas9mRNA with sgRNA, micro-injecting a mixture into a bombyx mori egg, identifying genotype through PCR (polymerase chain reaction), screening out heterozygotes, and mutually mating the heterozygotes to obtain F1 generation in which pure heterozygotes appear; performing genotype detection on bombyx mori with phenotype, mating the bombyx mori with same genotype, screening out homozygotes which can be stably inherited to next generation, and then screening out the bombyx mori silk fibroin heavy chain gene mutant, wherein a core sequence of sgRNA is designed aiming at 1213-1236, 1274-1297 or 1349-1372 loci of bombyx mori silk fibroin heavy chain gene. By the method, an experiment material having economic value and scientific value is obtained quickly and efficiently, and a new material is provided for large-scale production of bombyx mori sericine cocoon and enabling the bombyx mori to serve as a bioreactor to express foreign protein.
Owner:云南纳博生物科技有限公司

Human body beta-amyloid protein detection kit and application thereof

The invention relates to a human body beta-amyloid protein detection kit and application thereof. The human body beta-amyloid protein detection kit is prepared by the following steps: firstly, immunizing a mouse by use of antigen beta-amyloid precursor protein, separating out obvious lymph nodes in the spleen and the body of the mouse after confirming successful immunization, extracting total RNAs (Ribose Nucleic Acids), performing reverse transcription on the total RNAs to obtain cDNAs (complementary Desoxvribose Nucleic Acids), and amplifying the light and heavy chain genes of an antibody by virtue of PCR (Polymerase Chain Reaction); secondly, assembling and amplifying scFvDNA and constructing pCANTAB5E-scFv recombinant plasmid; thirdly, converting the plasmid to obtain a single-chain antibody phage library, and screening out to obtain target antibodies; and finally, assembling the target antibodies to form the human body beta-amyloid protein detection kit. The detection range of the screened antibodies is relatively wide from 0 to 1,000pg / ml, the linear correlation coefficient of the kit is high, the detection sensitivity of the kit can be 3.5pg / ml, and the kit achieves high stability; during detection, the reaction patterns of a two-step method and a room temperature oscillating method can be adopted, with low requirements on the laboratory conditions and the equipment.
Owner:苏州依科赛生物科技股份有限公司

Bombyx mori fibroin heavy chain expression system for expressing target protein distributed on fibroin and sericin, and preparation method and application

The invention discloses a bombyx mori fibroin heavy chain expression system for fibroin and sericin expressing a target protein, and a preparation method and application of the bombyx mori fibroin heavy chain expression system. The expression system contains a fibroin heavy chain promoter 3 at the 5' end and an expression cassette of a heavy chain gene poly(A) sequence at the 3' end. The system isused to express a foreign protein, through the identification and detection analysis of transgenic bombyx mori, it is found that the presence of EGFP is detected in both the silk gland and the silk,and EGFP is also distributed in the sericin layer in the silk, so that the result indicates that in the absence of the C-terminal, the N-terminal is not an essential factor for the formation of the silk, and the absence of the C-terminal can make the protein be distributed in the sericin layer. The analysis of the N-terminal of fibroin provides an experimental and theoretical basis for the silk formation mechanism of the silk, and is conducive to creating a really practical bombyx mori silk gland bioreactor, maintaining the sustainable development of the silk industry, and promoting the long-term development of sericulture and insect science in China.
Owner:重庆西蚕生物技术研究院有限公司 +1

Fully humanized single-domain antibody for CD16, antigen combining fragment of antibody and applications

The invention belongs to the biotechnological field and particularly relates to a fully humanized single-domain antibody for CD16, an antigen combining fragment of the antibody and applications of theantibody and the antigen combining fragment in preparation of preparations for disease diagnosis and treatment. The invention discloses the fully humanized single-domain antibody capable of specifically combining CD16 or the antigen combining fragment of the antibody. The single-domain antibody is mainly characterized by being determined by a CDR (complementarity-determining region) specific genesequence existing in an antibody heavy chain gene variable region, and the effectively expressed antibody specifically combined with the CD16 is obtained from prokaryotic and eukaryotic cells. Different forms of genetically engineered antibodies can be modified and produced in prokaryotic and eukaryotic cells and any expression system by use of the CDR or partial or full gene of the body, and theantibody can be used for preparing preparations for clinical diagnosis or treatment of related diseases.
Owner:FUDAN UNIV

Recombinant oncolytic vaccinia virus, preparation method and application thereof

The invention discloses a recombinant oncolytic vaccinia virus, a preparation method and application thereof. A thymidine kinase TK region of a genome of a recombinant oncolytic vaccinia virus comprises an anti-mouse / human TIGIT antibody genetic sequence, and the thymidine kinase TK region of the genome of the recombinant oncolytic vaccinia virus can express an anti-mouse / human TIGIT antibody. Theanti-mouse / human TIGIT antibody genetic sequence is formed by connecting an antibody heavy chain gene, 2A peptide and an antibody light chain gene in series, and the nucleotide sequence of the anti-mouse / human TIGIT antibody gene is shown as SEQ ID NO. 1. The recombinant oncolytic vaccinia virus oncolytic virus kills tumors through direct oncolysis and activation of a human immune system. The oncolytic vaccinia virus can effectively activate the immune response of T cells to tumor cells so as to exert multiple anti-tumor effects.
Owner:NANJING VIROTHER BIOPHARMACEUTICAL CO LTD

Efficient expression vector of antibody and preparation method for efficient expression vector

The invention discloses an efficient expression vector of an antibody. The efficient expression vector contains resistance genes and two target gene binding sites for binding the genes, the two target gene binding sites can be respectively combined with heavy chain genes and light chain genes of antibody molecules, the two target gene binding sites are respectively positioned in two expression units in the efficient expression vector and respectively form a heavy chain expression unit and a light chain expression unit of the antibody, and each expression unit also comprises a strong expression inductivity promoter positioned on the upstream of each target gene binding site. The efficient expression vector can simultaneously express the heavy chain and the light chain of the antibody, solve the problem about imbalanced expression of the heavy chain and the light chain of the antibody in the prior art, increase the expression rate of antibody protein and improve the screening effectiveness of subsequent monoclonal antibody cell strains.
Owner:广东安普泽生物医药股份有限公司

Anti-schistosomiasis monoclonal antibody NP11-4 single-chain antibody, preparation and use thereof

The invention discloses a single-chain antibody of an anti-schistosome monoclonal NP11-4 as well as a preparation method and application thereof, and relates to the field of gene engineering and the field of therapeutic drugs against schistosomiasis. The invention is to use a monoclonal antibody NP11-4 located at adult membrane, cercaria memberane, schistosomulum membrane, egg shell and miracidium in egg of Schistosoma japonicum, extract total RNA of hybridoma cells through a gene engineering technology, adopt RT-PCR for proliferation of genes VH and VL, and use overlap-extension PCR to connect the genes VH and VL into a single-chain antibody gene in the form of VH<-linker-VL, which is subsequently connected with a pBAD / gIIIA carrier and cloned into Top10F'of Escherichia Coli to induce a soluble expression of the target gene. The zone from amino acid No.1 to No. 122 of the expressed single-chain antibody of the anti-schistosome monoclonal NP11-4 is a heavy chain gene repertoire of the single-chain antibody (VH), and the zone from the amino acid No.141 to No.254 is a light chain gene repertoire (VL) of the single-chain antibody, wherein the linker between the heavy and light chain gene repertoires consists of 18 amino acids including repeated glycines and serines, and the single-chain antibody has 254 amino acids in full length.
Owner:NANJING MEDICAL UNIV

Method for rapidly obtaining coding region sequence of goose ferritin heavy-chain gene and quantitatively detecting expression of gene, and primers thereof

The invention discloses a method for rapidly obtaining the coding region sequence of a goose ferritin heavy-chain gene and quantitatively detecting the expression of the gene, and primers thereof. The method comprises the following steps: extracting the total RNA from goose tissues, carrying out inverse transcription, and designing an FTH coding region sequence primer FTH-L (SEQ ID NO:1-2) and an FTH expression rule detection primer FTH-S (SEQ ID NO:3-4); and carrying out RT-PCR amplification, recovering and purifying the obtained product, carrying out target gene connection and conversion, and screening and sequencing a positive bacterial colony to obtain the FTH coding region sequence and the sequencing identification fluorescence quantitative PCR primers. The method has the advantages of low cost, high efficiency, obtaining of the complete coding region sequence only through one-time cloning, and rapid and accurate detection of the expression rule of the FTH in samples of different tissues and different growth periods, and lays a theoretic foundation for the clarification of the FTH structure and function, and the researches of the iron metabolism mechanism in the goose.
Owner:SICHUAN AGRI UNIV

Bispecific antibody targeting NKG2A and PD-L1 and application

According to the invention, based on the reported light and heavy chain amino acid sequences of the anti-NKG2A antibody in the prior art, the method comprises the steps of: constructing a light and heavy chain mutation antibody library for affinity maturation to obtain the mutant antibody with improved affinity and / or improved dissociation constant; and constructing a human Fab heavy chain gene expression vector and a mammalian cell expression vector containing a human kappa subtype light chain constant region gene in a CDRs region of a mutant antibody, carrying out cross pairing on a heavy chain vector and a light chain vector of an antibody with mature affinity, screening to obtain an anti-NKG2A mutant Fab antibody, and connecting an Fc segment of the human antibody; and connecting a second antigen binding molecule (such as an anti-PD-L1 antibody) to the C end of the Fc segment through linker to obtain the bispecific antibody.
Owner:MABWELL (SHANGHAI) BIOSCIENCE CO LTD

Phage antibody library and application thereof in avian influenza immunodetection

The invention relates to an antibody library. An immune globulin light chain variable region VL gene sequence is inserted between Xba and Sac restriction enzyme cutting sites of a Pcomb3 vector. An immune globulin heavy chain variable region VH gene sequence is inserted between Spe and Xho endo restriction enzyme cutting sites. The antibody library is characterized in that two gene fragments comprise the possible combination of antibody variable region light chain and heavy chain, and the antibody library can realize affinity enrichment with an avian influenza virus antigen, and can be applied to avian influenza immunodetection. The antibody library has the advantages that a high affinity antibody can be acquired without animal immunity; a preparation period is short; the antibody library is a phage antibody library which is constructed by taking mice natural immune globulin variable region light chain and heavy chain genes as sources, theoretically contains all possible antibodies in a mice, and is a specificity antibody library which can directly acquire different avian influenza viruses through screening; and the screening has the advantages of high efficiency, high flux, large selection base and high specificity, thus the phage antibody library has a wide application prospect in the aspect of the disease detection of avian influenza and other animals.
Owner:BEIJING ENTRY EXIT INSPECTION & QUARANTINE BUREAU INSPECTION & QUARANTINE TECH CENT +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products